๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Measurement of Plasma Angiotensin II: Purification by Cation-Exchange Chromatography

โœ Scribed by B.J. Ledwith; M.K. Cahill; L.S. Losse; S.M. Satiritz; R.S. Eydelloth; A.L. Dallob; W.K. Tanaka; S.M. Galloway; W.W. Nichols


Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
641 KB
Volume
213
Category
Article
ISSN
0003-2697

No coin nor oath required. For personal study only.

โœฆ Synopsis


Measurement of plasma angiotensin II (AII) by radioimmunoassay (RIA) usually requires prior purification of the plasma to remove substances that cross-react in the RIA, most notably angiotensin III (AIII). Purification of AII is generally accomplished by solid-phase extraction (SPE) followed by reverse-phase HPLC, with tedious evaporation and resuspension steps in between, and requires collection of many HPLC fractions per sample for RIA. In this report, we describe a rapid twostep SPE procedure for the purification of plasma AII, including an improved protease inhibitor cocktail for preventing the formation or degradation of AII in vitro. Plasma is first extracted on an S-Sepharose cation-exchange column, in which AII is separated from AIII by virtue of their difference in net charge, and then extracted on a C8 SPE column, without need for intermediate sample handling. The two-step SPE method is fast, results in only a single fraction for RIA per sample, and yields consistently high recoveries ((77-86 %)) of AII, reducing the volume of plasma needed from 2 to 0.5 ml. Rat plasma was used in the present study, but the complete conservation of angiotensin peptide sequences (except angiotensinogen) in mammals suggests that this method will be applicable for other species including humans. In summary, the two-step SPE method offers the speed and simplicity of solid phase extraction while achieving a purity in AII (i.e., free of AIII) previously only obtained by laborious procedures involving HPLC. 1993 Academic Press, Inc.


๐Ÿ“œ SIMILAR VOLUMES


Growth of Enterococcus mundtii ST15 in m
โœ Monique Granger; Svetoslav D. Todorov; Mark K. A. Matthew; Leon M. T. Dicks ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB

Bacteriocin ST15 (bacST15), produced by Enterococcus mundtii ST15, inhibited the growth of a variety of bacteria, including exopolysaccharide (EPS)-producing strains isolated from biofilms in stainless steel pipes. Maximal production of bacST15 (51 200 AU/ml) was recorded after 20 h of growth in MRS